Facebook
X
LinkedIn
Forward
Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
This activity will provide an interdisciplinary educational forum in which to update state-of-the-art science including novel therapies for inherited cancers, discuss real-world cases, curate interesting pedigrees, and prepare case summaries to disseminate new knowledge in translational genomics and evidence-based clinical management of high-risk patients and their family members.
 This activity is brought to you in partnership with City of Hope. |
Click here to tour the virtual conference room!
CONFERENCE PREVIEW
Target Audience
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Recall advanced concepts in genetics, genomics, and next generation sequencing (NGS) technologies;
- Analyze controversies in cancer risk assessment and genetic testing including the integration of polygenic risk scores;
- Recognize how scientific advances in Lynch syndrome and other inherited solid tumors and hematologic malignancies can improve the clinical management of patients;
- Discuss how the integration of novel cancer therapies based on genomic alterations in tumor tissue may reveal germline mutations that can guide patient management;
- Recognize the limitations of genomic testing as it relates to both cancer risk as well as therapeutic selection, including variants of uncertain significance and in silico predictions;
- Identify how a globally-informed perspective on experimental therapeutics for rare cancers including immunotherapy can improve patient outcomes;
- Discuss how emerging concepts in cancer interception and cancer risk modifiers including lifestyle and chemoprevention can impact disease management strategies;
- State the ethical, legal, and social implications of genomic testing in diverse populations.
Agenda subject to change.
THIS ACTIVITY WILL NOW BE OFFERED VIA WEBCONFERENCE!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Meeting Achievements via email at [email protected].
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
CONFERENCE LEADERSHIP
Olufunmilayo Falusi Olopade, MBBS, FACPWalter L. Palmer Distinguished Service Professor
Director, Center for Clinical Cancer Genetics
Departments of Medicine and Human Genetics
University of Chicago
Walter M. Stadler, MDFred C. Buffett Professor of Medicine and Surgery
Dean for Clinical Research
Director, Genitourinary Oncology Program
Deputy Director, Comprehensive Cancer Center
University of Chicago
Kathleen Blazer, EdD, MS, LCGCClinical Assistant Professor
Associate Director, Cancer Genomics Education Program
Co-Director, Intensive Course in Cancer Risk Assessment
Co-Investigator, Cancer Genomics Career Development Program
City of Hope National Medical Center
Iris Romero, MDAssociate Professor of Obstetrics & Gynecology
Associate Director, Center for Clinical Cancer Genetics
University of Chicago
Jeffrey N. Weitzel, MDDr. Norman & Melinda Payson Professor in Medical Oncology
Director, Division of Clinical Cancer Genomics, Department of Population Sciences
Director, Cancer Screening & Prevention Programs Network
Director, Cancer Genomics Education Program
City of Hope National Medical Center
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 17.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Society of Genetic Counselors (NSGC) has authorized University of Chicago Pritzker School of Medicine to offer up to 1.635 CEUs or 16.35 Category 1 contact hours for the activity 9th Annual Clinical Cancer Genetics and Genomics Conference. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Healthcare Professional Credit
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
REGISTRATION
Please log in or create an account to register. Once logged in, select the profession type that best suits you and click "Register Now!".
Profession Type | Registration Fee |
|---|---|
Physician | $545 |
Genetic Counselor (Does not include CEU credit) | $350 |
Genetic Counselor + $25 CEU Fee | $375 |
Other Healthcare Professionals | $350 |
Resident/Fellow | $245 |
| Industry | $600 |
| CANCELLATION POLICY If you cancel your participation in this conference, your registration fee less a $100 administrative fee will be refunded when written notification is received by March 15, 2020. No refunds will be made after March 15, 2020. | |
ALREADY REGISTERED?
CLAIMING CREDIT
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 CreditTM credit after three months will be subject to additional fees. The NSGC requires that all CEUs are reported to them within 60 days of the activity.